Ultralife Co. (NASDAQ:ULBI) Shares Bought by Barclays PLC

Barclays PLC raised its position in Ultralife Co. (NASDAQ:ULBI) by 21.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,395 shares of the technology company’s stock after acquiring an additional 2,355 shares during the period. Barclays PLC owned approximately 0.08% of Ultralife worth $121,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of ULBI. Dimensional Fund Advisors LP boosted its stake in Ultralife by 5.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,024,491 shares of the technology company’s stock valued at $10,880,000 after acquiring an additional 51,399 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in shares of Ultralife by 203.1% during the second quarter. Bank of New York Mellon Corp now owns 39,111 shares of the technology company’s stock worth $415,000 after buying an additional 26,206 shares during the period. XTX Topco Ltd lifted its stake in shares of Ultralife by 192.1% during the second quarter. XTX Topco Ltd now owns 37,399 shares of the technology company’s stock worth $397,000 after buying an additional 24,595 shares during the period. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Ultralife by 15.5% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 157,330 shares of the technology company’s stock worth $1,422,000 after buying an additional 21,140 shares during the period. Finally, Renaissance Technologies LLC lifted its stake in shares of Ultralife by 9.1% during the second quarter. Renaissance Technologies LLC now owns 242,490 shares of the technology company’s stock worth $2,575,000 after buying an additional 20,300 shares during the period. 30.68% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on ULBI shares. Benchmark reiterated a “buy” rating and set a $14.00 price objective on shares of Ultralife in a research note on Friday, November 15th. StockNews.com cut shares of Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, October 3rd.

Ultralife Stock Down 2.8 %

ULBI stock opened at $7.39 on Thursday. The stock has a market capitalization of $122.87 million, a P/E ratio of 13.44 and a beta of 0.96. The firm has a 50-day simple moving average of $7.74 and a 200-day simple moving average of $9.22. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. Ultralife Co. has a 52 week low of $6.63 and a 52 week high of $13.39.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.